ClostraBio Revenue and Competitors
Estimated Revenue & Valuation
- ClostraBio's estimated annual revenue is currently $852.5k per year.
- ClostraBio's estimated revenue per employee is $77,500
Employee Data
- ClostraBio has 11 Employees.
- ClostraBio grew their employee count by 22% last year.
ClostraBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | Co-founder and Advisor | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
ClostraBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.6M | 17 | -6% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $2.5M | 16 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 64% | N/A | N/A |
#5 | $38.4M | 248 | 18% | N/A | N/A |
#6 | $2M | 13 | -24% | N/A | N/A |
#7 | $1.4M | 9 | -25% | N/A | N/A |
#8 | $1.4M | 9 | 0% | N/A | N/A |
#9 | $2.5M | 16 | 7% | N/A | N/A |
#10 | $2.3M | 15 | 150% | N/A | N/A |
What Is ClostraBio?
Utilizing a novel polymer platform for targeted delivery of bacterial metabolites to the gut, ClostraBio is dedicated to treating ulcerative colitis and food allergy. Our team is breaking new ground in treatments that restore compromised protective intestinal barrier function. We are exploring the therapeutic potential of the bacterial metabolites as treatments for immune-mediated diseases, particularly IBD and food allergy. Visit us at www.clostrabio.com to learn more!
keywords:N/A
N/A
Total Funding
11
Number of Employees
$852.5k
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Chicago
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.2M | 11 | 0% | N/A |
#2 | $1M | 11 | N/A | N/A |
#3 | $1M | 11 | N/A | N/A |
#4 | $1M | 11 | N/A | N/A |
#5 | $1.1M | 11 | N/A | N/A |